C. Quan

Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β

P. Weinreb, T. Walz, K. P. Kilambi, 2018, Scientific Reports.

EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies

H. Cooke, J. Arndt, M. Preyer, 2018, mAbs.

Characterization of tau binding by gosuranemab

J. Trojanowski, V. Lee, Richelle Sopko, 2020, Neurobiology of Disease.

Investigating the Role of Artemin Glycosylation

K. Rand, Christian Code, J. Arndt, 2016, Pharmaceutical Research.

ROLE OF PEPTIDYLARGININE DEIMINASE AND NEUTROPHIL EXTRACELLULAR TRAPS IN INJURIES: FUTURE NOVEL DIAGNOSTICS AND THERAPEUTIC TARGETS

H. Alam, Yongqing Li, C. Quan, 2023, Shock.

Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β

P. Weinreb, T. Walz, K. P. Kilambi, 2018, Scientific Reports.

Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models

R. Nitsch, P. Auluck, P. Weinreb, 2019, Neurobiology of Disease.

Structure of the LINGO-1–Anti-LINGO-1 Li81 Antibody Complex Provides Insights into the Biology of LINGO-1 and the Mechanism of Action of the Antibody Therapy

S. Mi, X. Lee, Omar Quintero-Monzon, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Investigating the Role of Artemin Glycosylation

K. Rand, Christian Code, J. Arndt, 2016, Pharmaceutical Research.